How big is the rheumatology therapeutics market?

A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market.The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7 from 2017 to 2025.Market Analysis and Insights Global Rheumatology Therapeutics MarketThe global Rheumatology Therapeutics market size is projected to reach US XX million by 2027 from US XX million in 2020 at a CAGR of XX during 20212027.With industrystandard accuracy in analysis and high data integrity the report makes a brilliant attempt to unveil key opportunities available in the global Rheumatology Therapeutics market to help players in achieving a strong market position.

Global Rheumatology Therapeutics Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Rheumatology Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Q: Who are the key players in the rheumatology therapeutics market?

Some of the key players are AbbVie, Pfizer Inc, Bristol Myers Squibb Company, Merck, Amgen Inc, Janssen Biotech, Novartis, Genentech Inc, Takeda Pharmaceutical, Sanofi, China, AbbVie Inc, India, Others.

Code: QYRE-Auto-15M2331

Report

September 2022

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Pfizer Inc

Bristol Myers Squibb Company

Merck

Amgen Inc

Janssen Biotech

Novartis

Genentech Inc

Takeda Pharmaceutical

Sanofi

AbbVie Inc

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Rheumatology Therapeutics estimated at US$ 47500 million in the year 2022, is projected to reach a revised size of US$ 54090 million by 2028, growing at a CAGR of 2.2% during the forecast period 2022-2028.

The USA market for Rheumatology Therapeutics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Rheumatology Therapeutics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Rheumatology Therapeutics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key companies of Rheumatology Therapeutics include Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer and Bristol-Myers Squibb Company, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Rheumatology Therapeutics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Rheumatology Therapeutics market. Further, it explains the major drivers and regional dynamics of the global Rheumatology Therapeutics market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Takeda Pharmaceutical

Sanofi

Genentech

Novartis

Janssen Biotech

Amgen

AbbVie

Pfizer

Bristol-Myers Squibb Company

Merck & Co.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Rheumatology Therapeutics Segment by Type

Disease Modifying Anti-rheumatic Drugs

Nonsteroidal Anti-inflammatory Drugs

Corticosteroids

Uric Acid Drugs

Others

Rheumatology Therapeutics Segment by Application

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Rheumatology Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Rheumatology Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Rheumatology Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Rheumatology Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rheumatology Therapeutics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Rheumatology Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Rheumatology Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Takeda Pharmaceutical, Sanofi, Genentech, Novartis, Janssen Biotech, Amgen, AbbVie, Pfizer and Bristol-Myers Squibb Company, etc.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Rheumatology Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Disease Modifying Anti-rheumatic Drugs

1.2.3 Nonsteroidal Anti-inflammatory Drugs

1.2.4 Corticosteroids

1.2.5 Uric Acid Drugs

1.2.6 Others

1.3 Market by Application

1.3.1 Global Rheumatology Therapeutics Market Growth Rate by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Rheumatology Therapeutics Market Size (2017-2028)

2.2 Rheumatology Therapeutics Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.3 Global Rheumatology Therapeutics Market Size by Region (2017-2022)

2.4 Global Rheumatology Therapeutics Market Size Forecast by Region (2023-2028)

2.5 Global Top Rheumatology Therapeutics Countries Ranking by Market Size

3 Rheumatology Therapeutics Competitive by Company

3.1 Global Rheumatology Therapeutics Revenue by Players

3.1.1 Global Rheumatology Therapeutics Revenue by Players (2017-2022)

3.1.2 Global Rheumatology Therapeutics Market Share by Players (2017-2022)

3.2 Global Rheumatology Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Company Covered: Ranking by Rheumatology Therapeutics Revenue

3.4 Global Rheumatology Therapeutics Market Concentration Ratio

3.4.1 Global Rheumatology Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Therapeutics Revenue in 2021

3.5 Global Rheumatology Therapeutics Key Players Head office and Area Served

3.6 Key Players Rheumatology Therapeutics Product Solution and Service

3.7 Date of Enter into Rheumatology Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Rheumatology Therapeutics Breakdown Data by Type

4.1 Global Rheumatology Therapeutics Historic Revenue by Type (2017-2022)

4.2 Global Rheumatology Therapeutics Forecasted Revenue by Type (2023-2028)

5 Global Rheumatology Therapeutics Breakdown Data by Application

5.1 Global Rheumatology Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Rheumatology Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Rheumatology Therapeutics Revenue by Company (2020-2022)

6.2 North America Rheumatology Therapeutics Revenue by Type (2017-2028)

6.3 North America Rheumatology Therapeutics Revenue by Application (2017-2028)

6.4 North America Rheumatology Therapeutics Revenue by Country (2017-2028)

6.4.1 U.S.

6.4.2 Canada

7 Europe

7.1 Europe Rheumatology Therapeutics Revenue by Company (2020-2022)

7.2 Europe Rheumatology Therapeutics Revenue by Type (2017-2028)

7.3 Europe Rheumatology Therapeutics Revenue by Application (2017-2028)

7.4 Europe Rheumatology Therapeutics Revenue by Country (2017-2028)

7.4.1 Germany

7.4.2 France

7.4.3 U.K.

7.4.4 Italy

7.4.5 Russia

8 Asia Pacific

8.1 Asia Pacific Rheumatology Therapeutics Revenue by Company (2020-2022)

8.2 Asia Pacific Rheumatology Therapeutics Revenue by Type (2017-2028)

8.3 Asia Pacific Rheumatology Therapeutics Revenue by Application (2017-2028)

8.4 Asia Pacific Rheumatology Therapeutics Revenue by Region (2017-2028)

8.4.1 China

8.4.2 Japan

8.4.3 South Korea

8.4.4 India

8.4.5 Australia

8.4.6 Taiwan

8.4.7 Indonesia

8.4.8 Thailand

8.4.9 Malaysia

8.4.10 Philippines

8.4.11 Vietnam

9 Latin America

9.1 Latin America Rheumatology Therapeutics Revenue by Company (2020-2022)

9.2 Latin America Rheumatology Therapeutics Revenue by Type (2017-2028)

9.3 Latin America Rheumatology Therapeutics Revenue by Application (2017-2028)

9.4 Latin America Rheumatology Therapeutics Revenue by Country (2017-2028)

9.4.1 Mexico

9.4.2 Brazil

9.4.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Rheumatology Therapeutics Revenue by Company (2020-2022)

10.2 Middle East and Africa Rheumatology Therapeutics Revenue by Type (2017-2028)

10.3 Middle East and Africa Rheumatology Therapeutics Revenue by Application (2017-2028)

10.4 Middle East and Africa Rheumatology Therapeutics Revenue by Country (2017-2028)

10.4.1 Turkey

10.4.2 Saudi Arabia

10.4.3 UAE

11 Company Profiles

11.1 Takeda Pharmaceutical

11.1.1 Takeda Pharmaceutical Company Details

11.1.2 Takeda Pharmaceutical Business Overview

11.1.3 Takeda Pharmaceutical Rheumatology Therapeutics Products and Services

11.1.4 Takeda Pharmaceutical Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.1.5 Takeda Pharmaceutical Rheumatology Therapeutics SWOT Analysis

11.1.6 Takeda Pharmaceutical Recent Developments

11.2 Sanofi

11.2.1 Sanofi Company Details

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Rheumatology Therapeutics Products and Services

11.2.4 Sanofi Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.2.5 Sanofi Rheumatology Therapeutics SWOT Analysis

11.2.6 Sanofi Recent Developments

11.3 Genentech

11.3.1 Genentech Company Details

11.3.2 Genentech Business Overview

11.3.3 Genentech Rheumatology Therapeutics Products and Services

11.3.4 Genentech Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.3.5 Genentech Rheumatology Therapeutics SWOT Analysis

11.3.6 Genentech Recent Developments

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Rheumatology Therapeutics Products and Services

11.4.4 Novartis Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.4.5 Novartis Rheumatology Therapeutics SWOT Analysis

11.4.6 Novartis Recent Developments

11.5 Janssen Biotech

11.5.1 Janssen Biotech Company Details

11.5.2 Janssen Biotech Business Overview

11.5.3 Janssen Biotech Rheumatology Therapeutics Products and Services

11.5.4 Janssen Biotech Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.5.5 Janssen Biotech Rheumatology Therapeutics SWOT Analysis

11.5.6 Janssen Biotech Recent Developments

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Rheumatology Therapeutics Products and Services

11.6.4 Amgen Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.6.5 Amgen Rheumatology Therapeutics SWOT Analysis

11.6.6 Amgen Recent Developments

11.7 AbbVie

11.7.1 AbbVie Company Details

11.7.2 AbbVie Business Overview

11.7.3 AbbVie Rheumatology Therapeutics Products and Services

11.7.4 AbbVie Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.7.5 AbbVie Rheumatology Therapeutics SWOT Analysis

11.7.6 AbbVie Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Rheumatology Therapeutics Products and Services

11.8.4 Pfizer Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.8.5 Pfizer Rheumatology Therapeutics SWOT Analysis

11.8.6 Pfizer Recent Developments

11.9 Bristol-Myers Squibb Company

11.9.1 Bristol-Myers Squibb Company Company Details

11.9.2 Bristol-Myers Squibb Company Business Overview

11.9.3 Bristol-Myers Squibb Company Rheumatology Therapeutics Products and Services

11.9.4 Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.9.5 Bristol-Myers Squibb Company Rheumatology Therapeutics SWOT Analysis

11.9.6 Bristol-Myers Squibb Company Recent Developments

11.10 Merck & Co.

11.10.1 Merck & Co. Company Details

11.10.2 Merck & Co. Business Overview

11.10.3 Merck & Co. Rheumatology Therapeutics Products and Services

11.10.4 Merck & Co. Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022)

11.10.5 Merck & Co. Rheumatology Therapeutics SWOT Analysis

11.10.6 Merck & Co. Recent Developments

12 Rheumatology Therapeutics Market Dynamics

12.1 Rheumatology Therapeutics Market Trends

12.2 Rheumatology Therapeutics Market Drivers

12.3 Rheumatology Therapeutics Market Challenges

12.4 Rheumatology Therapeutics Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

FEATURED COMPANIES

AbbVie

Pfizer Inc

Bristol Myers Squibb Company

Merck

Amgen Inc

Janssen Biotech

Novartis

Genentech Inc

Takeda Pharmaceutical

Sanofi

AbbVie Inc

List of Tables

Table 1. Global Rheumatology Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs

Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs

Table 4. Key Players of Corticosteroids

Table 5. Key Players of Uric Acid Drugs

Table 6. Key Players of Others

Table 7. Global Rheumatology Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 8. Global Rheumatology Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 9. Global Rheumatology Therapeutics Revenue by Region (2017-2022) & (US$ Million)

Table 10. Global Rheumatology Therapeutics Revenue Market Share by Region (2017-2022)

Table 11. Global Rheumatology Therapeutics Revenue by Players (2017-2022) & (US$ Million)

Table 12. Global Rheumatology Therapeutics Market Share by Players (2017-2022)

Table 13. Global Top Rheumatology Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Therapeutics as of 2021)

Table 14. Ranking of Global Top Rheumatology Therapeutics Companies by Revenue (US$ Million) in 2021

Table 15. Global 5 Largest Players Market Share by Rheumatology Therapeutics Revenue (CR5 and HHI) & (2017-2022)

Table 16. Key Players Headquarters and Area Served

Table 17. Key Players Rheumatology Therapeutics Product Solution and Service

Table 18. Date of Key Manufacturers Enter into Rheumatology Therapeutics Market

Table 19. Mergers & Acquisitions, Expansion Plans

Table 20. Global Rheumatology Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 21. Global Rheumatology Therapeutics Revenue Market Share by Type (2017-2022)

Table 22. Global Rheumatology Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 23. Global Rheumatology Therapeutics Revenue Market Share by Type (2023-2028)

Table 24. Global Rheumatology Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 25. Global Rheumatology Therapeutics Revenue Market Share by Application (2017-2022)

Table 26. Global Rheumatology Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 27. Global Rheumatology Therapeutics Revenue Market Share by Application (2023-2028)

Table 28. North America Rheumatology Therapeutics Revenue by Company (2020-2022) & (US$ Million)

Table 29. North America Rheumatology Therapeutics Revenue by Type (2017-2022) & (US$ Million)

Table 30. North America Rheumatology Therapeutics Revenue by Type (2023-2028) & (US$ Million)

Table 31. North America Rheumatology Therapeutics Revenue by Application (2017-2022) & (US$ Million)

Table 32. North America Rheumatology Therapeutics Revenue by Application (2023-2028) & (US$ Million)

Table 33. North America Rheumatology Therapeutics Revenue by Country (2017-2022) & (US$ Million)

Table 34. North America Rheumatology Therapeutics Revenue by Country (2023-2028) & (US$ Million)

Table 35. Europe Rheumatology Therapeutics Revenue by Company (2020-2022) & (US$ Million)

Table 36. Europe Rheumatology Therapeutics Revenue by Type (2017-2022) & (US$ Million)

Table 37. Europe Rheumatology Therapeutics Revenue by Type (2023-2028) & (US$ Million)

Table 38. Europe Rheumatology Therapeutics Revenue by Application (2017-2022) & (US$ Million)

Table 39. Europe Rheumatology Therapeutics Revenue by Application (2023-2028) & (US$ Million)

Table 40. Europe Rheumatology Therapeutics Revenue by Country (2017-2022) & (US$ Million)

Table 41. Europe Rheumatology Therapeutics Revenue by Country (2023-2028) & (US$ Million)

Table 42. Asia Pacific Rheumatology Therapeutics Revenue by Company (2020-2022) & (US$ Million)

Table 43. Asia Pacific Rheumatology Therapeutics Revenue by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Rheumatology Therapeutics Revenue by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Rheumatology Therapeutics Revenue by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Rheumatology Therapeutics Revenue by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Rheumatology Therapeutics Revenue by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Rheumatology Therapeutics Revenue by Region (2023-2028) & (US$ Million)

Table 49. Latin America Rheumatology Therapeutics Revenue by Company (2020-2022) & (US$ Million)

Table 50. Latin America Rheumatology Therapeutics Revenue by Type (2017-2022) & (US$ Million)

Table 51. Latin America Rheumatology Therapeutics Revenue by Type (2023-2028) & (US$ Million)

Table 52. Latin America Rheumatology Therapeutics Revenue by Application (2017-2022) & (US$ Million)

Table 53. Latin America Rheumatology Therapeutics Revenue by Application (2023-2028) & (US$ Million)

Table 54. Latin America Rheumatology Therapeutics Revenue by Country (2017-2022) & (US$ Million)

Table 55. Latin America Rheumatology Therapeutics Revenue by Country (2023-2028) & (US$ Million)

Table 56. Middle East and Africa Rheumatology Therapeutics Revenue by Company (2020-2022) & (US$ Million)

Table 57. Middle East and Africa Rheumatology Therapeutics Revenue by Type (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Rheumatology Therapeutics Revenue by Type (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Rheumatology Therapeutics Revenue by Application (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Rheumatology Therapeutics Revenue by Application (2023-2028) & (US$ Million)

Table 61. Middle East and Africa Rheumatology Therapeutics Revenue by Country (2017-2022) & (US$ Million)

Table 62. Middle East and Africa Rheumatology Therapeutics Revenue by Country (2023-2028) & (US$ Million)

Table 63. Takeda Pharmaceutical Company Details

Table 64. Takeda Pharmaceutical Business Overview

Table 65. Takeda Pharmaceutical Rheumatology Therapeutics Product and Services

Table 66. Takeda Pharmaceutical Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 67. Takeda Pharmaceutical Rheumatology Therapeutics SWOT Analysis

Table 68. Takeda Pharmaceutical Recent Developments

Table 69. Sanofi Company Details

Table 70. Sanofi Business Overview

Table 71. Sanofi Rheumatology Therapeutics Product and Services

Table 72. Sanofi Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 73. Sanofi Rheumatology Therapeutics SWOT Analysis

Table 74. Sanofi Recent Developments

Table 75. Genentech Company Details

Table 76. Genentech Business Overview

Table 77. Genentech Rheumatology Therapeutics Product and Services

Table 78. Genentech Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 79. Genentech Rheumatology Therapeutics SWOT Analysis

Table 80. Genentech Recent Developments

Table 81. Novartis Company Details

Table 82. Novartis Business Overview

Table 83. Novartis Rheumatology Therapeutics Product and Services

Table 84. Novartis Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 85. Novartis Rheumatology Therapeutics SWOT Analysis

Table 86. Novartis Recent Developments

Table 87. Janssen Biotech Company Details

Table 88. Janssen Biotech Business Overview

Table 89. Janssen Biotech Rheumatology Therapeutics Product and Services

Table 90. Janssen Biotech Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 91. Janssen Biotech Rheumatology Therapeutics SWOT Analysis

Table 92. Janssen Biotech Recent Developments

Table 93. Amgen Company Details

Table 94. Amgen Business Overview

Table 95. Amgen Rheumatology Therapeutics Product and Services

Table 96. Amgen Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 97. Amgen Rheumatology Therapeutics SWOT Analysis

Table 98. Amgen Recent Developments

Table 99. AbbVie Company Details

Table 100. AbbVie Business Overview

Table 101. AbbVie Rheumatology Therapeutics Product and Services

Table 102. AbbVie Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 103. AbbVie Rheumatology Therapeutics SWOT Analysis

Table 104. AbbVie Recent Developments

Table 105. Pfizer Company Details

Table 106. Pfizer Business Overview

Table 107. Pfizer Rheumatology Therapeutics Product and Services

Table 108. Pfizer Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 109. Pfizer Rheumatology Therapeutics SWOT Analysis

Table 110. Pfizer Recent Developments

Table 111. Bristol-Myers Squibb Company Company Details

Table 112. Bristol-Myers Squibb Company Business Overview

Table 113. Bristol-Myers Squibb Company Rheumatology Therapeutics Product and Services

Table 114. Bristol-Myers Squibb Company Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 115. Bristol-Myers Squibb Company Rheumatology Therapeutics SWOT Analysis

Table 116. Bristol-Myers Squibb Company Recent Developments

Table 117. Merck & Co. Company Details

Table 118. Merck & Co. Business Overview

Table 119. Merck & Co. Rheumatology Therapeutics Product and Services

Table 120. Merck & Co. Rheumatology Therapeutics Revenue in Rheumatology Therapeutics Business (2017-2022) & (US$ Million)

Table 121. Merck & Co. Rheumatology Therapeutics SWOT Analysis

Table 122. Merck & Co. Recent Developments

Table 123. Rheumatology Therapeutics Market Trends

Table 124. Rheumatology Therapeutics Market Drivers

Table 125. Rheumatology Therapeutics Market Challenges

Table 126. Rheumatology Therapeutics Market Restraints

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Rheumatology Therapeutics Sales Market Share by Type: 2021 VS 2028

Figure 2. Disease Modifying Anti-rheumatic Drugs Features

Figure 3. Nonsteroidal Anti-inflammatory Drugs Features

Figure 4. Corticosteroids Features

Figure 5. Uric Acid Drugs Features

Figure 6. Others Features

Figure 7. Global Rheumatology Therapeutics Sales Market Share by Application: 2021 VS 2028

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Online Pharmacy Case Studies

Figure 11. Rheumatology Therapeutics Report Years Considered

Figure 12. Global Rheumatology Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Rheumatology Therapeutics Market Size 2017-2028 (US$ Million)

Figure 14. Global Rheumatology Therapeutics Market Size Market Share by Region: 2021 VS 2028

Figure 15. Global Rheumatology Therapeutics Revenue Market Share by Region in 2017 VS 2022

Figure 16. Global Top 10 Rheumatology Therapeutics Countries Ranking by Market Size (US$ Million) in 2021

Figure 17. Global Rheumatology Therapeutics Market Share by Players in 2021

Figure 18. Global Top Rheumatology Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Therapeutics as of 2021)

Figure 19. The Top 10 and 5 Players Market Share by Rheumatology Therapeutics Revenue in 2021

Figure 20. North America Rheumatology Therapeutics Revenue Market Share by Company in 2021

Figure 21. North America Rheumatology Therapeutics Revenue Market Share by Type (2017-2028)

Figure 22. North America Rheumatology Therapeutics Revenue Market Share by Application (2017-2028)

Figure 23. North America Rheumatology Therapeutics Revenue Share by Country (2017-2028)

Figure 24. U.S. Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 25. Canada Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 26. Europe Rheumatology Therapeutics Revenue Market Share by Company in 2021

Figure 27. Europe Rheumatology Therapeutics Revenue Market Share by Type (2017-2028)

Figure 28. Europe Rheumatology Therapeutics Revenue Market Share by Application (2017-2028)

Figure 29. Europe Rheumatology Therapeutics Revenue Share by Country (2017-2028)

Figure 30. Germany Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 31. France Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 32. U.K. Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 33. Italy Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 34. Russia Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 35. Asia Pacific Rheumatology Therapeutics Revenue Market Share by Company in 2021

Figure 36. Asia Pacific Rheumatology Therapeutics Revenue Market Share by Type (2017-2028)

Figure 37. Asia Pacific Rheumatology Therapeutics Revenue Market Share by Application (2017-2028)

Figure 38. Asia Pacific Rheumatology Therapeutics Revenue Share by Region (2017-2028)

Figure 39. China Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 40. Japan Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 41. South Korea Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 42. India Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 43. Australia Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 44. Taiwan Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 45. Indonesia Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 46. Thailand Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 47. Malaysia Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 48. Philippines Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 49. Vietnam Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 50. Latin America Rheumatology Therapeutics Revenue Market Share by Company in 2021

Figure 51. Latin America Rheumatology Therapeutics Revenue Market Share by Type (2017-2028)

Figure 52. Latin America Rheumatology Therapeutics Revenue Market Share by Application (2017-2028)

Figure 53. Latin America Rheumatology Therapeutics Revenue Share by Country (2017-2028)

Figure 54. Mexico Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 55. Brazil Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 56. Argentina Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 57. Middle East and Africa Rheumatology Therapeutics Revenue Market Share by Company in 2021

Figure 58. Middle East and Africa Rheumatology Therapeutics Revenue Market Share by Type (2017-2028)

Figure 59. Middle East and Africa Rheumatology Therapeutics Revenue Market Share by Application (2017-2028)

Figure 60. Middle East and Africa Rheumatology Therapeutics Revenue Share by Country (2017-2028)

Figure 61. Turkey Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 62. Saudi Arabia Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 63. UAE Rheumatology Therapeutics Revenue (2017-2028) & (US$ Million)

Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 65. Sanofi Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 66. Genentech Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 67. Novartis Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 68. Janssen Biotech Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 69. Amgen Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 70. AbbVie Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 71. Pfizer Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 72. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 73. Merck & Co. Revenue Growth Rate in Rheumatology Therapeutics Business (2017-2022)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

Global Rheumatology Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: September 2022

Report Code: QYRE-Auto-15M2331

Global Rheumatology Therapeutics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Rheumatology Therapeutics Segment by Type

Rheumatology Therapeutics Segment by Application

FEATURED COMPANIES